Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer

被引:134
|
作者
Galvan, J. A. [1 ]
Zlobec, I. [1 ]
Wartenberg, M. [1 ,2 ]
Lugli, A. [1 ,2 ]
Gloor, B. [3 ]
Perren, A. [1 ,2 ]
Karamitopoulou, E. [1 ,2 ]
机构
[1] Univ Bern, Inst Pathol, Translat Res Unit, CH-3010 Bern, Switzerland
[2] Univ Bern, Inst Pathol, Div Clin Pathol, CH-3010 Bern, Switzerland
[3] Inselspital Bern, Dept Visceral Surg, CH-3010 Bern, Switzerland
关键词
epithelial-mesenchymal transition; tumour budding; tumour-stroma; tumour microenvironment; ZEB1; ZEB2; EPITHELIAL-MESENCHYMAL TRANSITION; COLORECTAL-CANCER; STEM-CELLS; BETA-CATENIN; COLON-CANCER; HIGH-RISK; TGF-BETA; STAGE-II; CARCINOMA; MARKER;
D O I
10.1038/bjc.2015.177
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: There is evidence that tumour-stroma interactions have a major role in the neoplastic progression of pancreatic ductal adenocarcinoma (PDAC). Tumour budding is thought to reflect the process of epithelial-mesenchymal transition (EMT); however, the relationship between tumour buds and EMT remains unclear. Here we characterize the tumour-budding-and stromal cells in PDAC at protein and mRNA levels concerning factors involved in EMT. Methods: mRNA in situ hybridisation and immunostaining for E-cadherin, beta-catenin, SNAIL1, ZEB1, ZEB2, N-cadherin and TWIST1 were assessed in the main tumour, tumour buds and tumour stroma on multipunch tissue microarrays from 120 well-characterised PDACs and associated with the clinicopathological features, including peritumoural (PTB) and intratumoural (ITB) budding. Results: Tumour-budding cells showed increased levels of ZEB1 (Po0.0001) and ZEB2 (P = 0.0119) and reduced E-cadherin and b-catenin (P<0.0001, each) compared with the main tumour. Loss of membranous beta-catenin in the main tumour (P = 0.0009) and tumour buds (P = 0.0053), without nuclear translocation, as well as increased SNAIL1 in tumour and stromal cells (P = 0.0002, each) correlated with high PTB. ZEB1 overexpression in the main tumour-budding and stromal cells was associated with high ITB (P = 0.0084; 0.0250 and 0.0029, respectively) and high PTB (P = 0.0005; 0.0392 and 0.0007, respectively). ZEB2 overexpression in stromal cells correlated with higher pT stage (P = 0.03), lymphatic invasion (P = 0.0172) and lymph node metastasis (P = 0.0152). Conclusions: In the tumour microenvironment of phenotypically aggressive PDAC, tumour-budding cells express EMT hallmarks at protein and mRNA levels underlining their EMT-type character and are surrounded by stromal cells expressing high levels of the E-cadherin repressors ZEB1, ZEB2 and SNAIL1, this being strongly associated with the tumour-budding phenotype. Moreover, our findings suggest the existence of subtypes of stromal cells in PDAC with phenotypical and functional heterogeneity.
引用
收藏
页码:1944 / 1950
页数:7
相关论文
共 10 条
  • [1] Expression of the E-cadherin repressors Snail, Slug and Zeb1 in urothelial carcinoma of the urinary bladder: relation to stromal fibroblast activation and invasive behaviour of carcinoma cells
    Schulte, Julia
    Weidig, Michaela
    Balzer, Philipp
    Richter, Petra
    Franz, Marcus
    Junker, Kerstin
    Gajda, Mieczyslaw
    Friedrich, Karlheinz
    Wunderlich, Heiko
    Ostman, Arne
    Petersen, Iver
    Berndt, Alexander
    HISTOCHEMISTRY AND CELL BIOLOGY, 2012, 138 (06) : 847 - 860
  • [2] Comparison of Snail1, ZEB1, E-Cadherin Expression Levels in HPV-Induced Cervical Cancer
    Farzanehpour, Mahdieh
    Faghihloo, Ebrahim
    Salimi, Vahid
    Jalilvand, Somayeh
    Akhavan, Setareh
    Muhammadnejad, Ahad
    Razavi, Amir Nader Emami
    Kakavandi, Ehsan
    Azad, Talat Mokhtari
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2020, 49 (11) : 2179 - 2188
  • [3] Downregulated microRNA-200a promotes EMT and tumor growth through the Wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma
    Cong, Ningning
    Du, Ping
    Zhang, Anling
    Shen, Fajuan
    Su, Juan
    Pu, Peiyu
    Wang, Tao
    Zjang, Jie
    Kang, Chunsheng
    Zhang, Qingyu
    ONCOLOGY REPORTS, 2013, 29 (04) : 1579 - 1587
  • [4] Ets1 and ESE1 reciprocally regulate expression of ZEB1/ZEB2, dependent on ERK1/2 activity, in breast cancer cells
    Nguyen Duy Sinh
    Endo, Kaori
    Miyazawa, Keiji
    Saitoh, Masao
    CANCER SCIENCE, 2017, 108 (05): : 952 - 960
  • [5] ZEB1 Collaborates with ELK3 to Repress E-Cadherin Expression in Triple-Negative Breast Cancer Cells
    Cho, Hyeon-Ju
    Oh, Nuri
    Park, Ji-Hoon
    Kim, Kwang-Soo
    Kim, Hyung-Keun
    Lee, Eunbyeol
    Hwang, Sohyun
    Kim, Seong-Jin
    Park, Kyung-Soon
    MOLECULAR CANCER RESEARCH, 2019, 17 (11) : 2257 - 2266
  • [6] SPARC Induces E-Cadherin Repression and Enhances Cell Migration through Integrin αvβ3 and the Transcription Factor ZEB1 in Prostate Cancer Cells
    Lopez-Moncada, Fernanda
    Jose Torres, Maria
    Lavanderos, Boris
    Cerda, Oscar
    Castellon, Enrique A.
    Contreras, Hector R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (11)
  • [7] miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2
    Ma, Peng
    Ni, Kan
    Ke, Jing
    Zhang, Wenyi
    Feng, Ying
    Mao, Qinsheng
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2018, 243 (05) : 473 - 480
  • [8] Claudin-1 Up-regulates the Repressor ZEB-1 to Inhibit E-Cadherin Expression in Colon Cancer Cells
    Singh, Amar B.
    Sharma, Ashok
    Smith, J. Joshua
    Krishnan, Moorthy
    Chen, Xi
    Eschrich, Steven
    Washington, Mary K.
    Yeatman, Timothy J.
    Beauchamp, R. Daniel
    Dhawan, Punita
    GASTROENTEROLOGY, 2011, 141 (06) : 2140 - 2153
  • [9] Prognostic significance of Zinc finger E-box binding homeobox 1 (ZEB1) expression in cancer cells and cancer-associated fibroblasts in pancreatic head cancer
    Bronsert, Peter
    Kohler, Ilona
    Timme, Sylvia
    Kiefer, Selina
    Werner, Martin
    Schilling, Oliver
    Vashist, Yogesh
    Makowiec, Frank
    Brabletz, Thomas
    Hopt, Ulrich T.
    Bausch, Dirk
    Kulemann, Birte
    Keck, Tobias
    Wellner, Ulrich E.
    SURGERY, 2014, 156 (01) : 97 - 108
  • [10] Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis
    Autanski, Dirniter B.
    Nagalingam, Arumugam
    Bonner, Michael Y.
    Arbiser, Jack L.
    Saxena, Neeraj K.
    Sharma, Dipali
    MOLECULAR ONCOLOGY, 2014, 8 (03): : 565 - 580